Dr. Jag Chhatwal has announced Dr. Carrie Cunningham (nee Lubitz) is the Associate Director of the Institute for Technology Assessment (ITA).
Dr. Cunningham is an Associate Professor of Surgery at Harvard Medical School, Section head of the Massachusetts General Hospital Endocrine Surgery Unit, and has been a Senior Scientist at the ITA since 2013. Dr. Cunningham matriculated at the University of Michigan for undergraduate and medical school and is a graduate of the NYPH/Weill Cornell Medical College general surgery residency. She then completed her clinical endocrine surgery fellowship in 2010 at the Massachusetts General Hospital and obtained a Master of Public Health through the Harvard School of Public Health and was a fellow in the Dana-Farber/Harvard Cancer Center Program in Cancer Outcomes Research Training. In 2015, Dr. Cunningham was one of the recipients of the Claflin Distinguished Scholars Award at MGH. She is the current President of the Association for Academic Surgery. Her overarching research mission has been to improve the health and well-being of patients with benign and malignant endocrine-related diseases and to mentor young academic surgeons. She is the principal investigator of an NIH/NCI R-37 (R01-type merit award) award to examine the potential impact of new diagnostic technologies and personalized management strategies in patients with thyroid cancer using mathematical disease simulation modeling and an American Cancer Society Research Scholar Award to develop a patient-reported instrument to assess thyroid-cancer specific quality of life.